​Intra-Cellular Therapies appoints chief compliance officer

Intra-Cellular Therapies, a biopharmaceutical company, has appointed Karen Sheehy as chief compliance officer.

THIS IS MEMBERS-ONLY CONTENT

Already a Member? SIGN IN here. If you’re not, click HERE for more information on our 30-day free trials and why you’re not able to view this story.